Table 2.
Summarized role of diagnostic tests, surveillance, and vaccines in the national and regional malaria elimination programs
| Parameter | Description | Reference |
|---|---|---|
| Guidelines |
• For training on the use of variously approved diagnostic methods such as microscopy and RDT. • Treatment guidelines for health professionals and health care workers. • Guideline for community private drug peddlers and retailers. |
Tetteh et al. 2021 Ansah et al. 2015 Bruxvoort et al. 2013 |
| Surveillance system |
• An adequate supply of technologically relevant surveillance tools in malaria-affected regions. • Implementation of the surveillance system for monitoring infections and progress toward elimination. • Regular training and retraining on surveillance for monitoring and evaluation officers. • Strengthening surveillance systems to involve private health sectors. • Integration of upcoming technology into a currently existing system for enhancing surveillance efficiency, especially in post elimination regions. |
Barclay et al. 2012 Bridges et al. 2012 Lourenço et al. 2019 WHO 2018 Yukich et al. 2014 |
| Vaccine |
• Financial investments in promoting malaria vaccine research and production. • Development of vaccines with high efficacy, minimal side effect, and wide acceptability. • Promoting vaccine literacy among less-educated communities to enhance vaccine acceptability. |
Targett and Greenwood 2008 Healer et al. 2017 Dimala et al. 2018 |